Integral Health Asset Management, LLC Moon Lake Immunotherapeutics Transaction History
Integral Health Asset Management, LLC
- $850 Million
- Q3 2024
A detailed history of Integral Health Asset Management, LLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 220,000 shares of MLTX stock, worth $11.6 Million. This represents 1.3% of its overall portfolio holdings.
Number of Shares
220,000
Previous 220,000
-0.0%
Holding current value
$11.6 Million
Previous $9.67 Million
14.67%
% of portfolio
1.3%
Previous 0.93%
Shares
3 transactions
Others Institutions Holding MLTX
# of Institutions
124Shares Held
58.2MCall Options Held
52.2KPut Options Held
38K-
Bvf Inc San Francisco, CA21.8MShares$1.15 Billion34.86% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$447 Million30.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.98MShares$157 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$146 Million2.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.32MShares$122 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.94B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...